GRMN
43
-2
CNP
70
2
SWKS
37
5
ORLY
65
-4
NTRS
37
-3
EXPE
70
-2
PDCO
69
-2
SLB
53
-2
HST
30
-2
MAS
50
-10
FOXA
63
-3
TXT
55
-8
MPC
41
-3
SRE
42
-3
UNM
65
-3
GOOG
42
-11
INTU
61
-5
EQIX
50
-3
ITW
31
-2
TGT
40
-4
GRMN
43
-2
CNP
70
2
SWKS
37
5
ORLY
65
-4
NTRS
37
-3
EXPE
70
-2
PDCO
69
-2
SLB
53
-2
HST
30
-2
MAS
50
-10
FOXA
63
-3
TXT
55
-8
MPC
41
-3
SRE
42
-3
UNM
65
-3
GOOG
42
-11
INTU
61
-5
EQIX
50
-3
ITW
31
-2
TGT
40
-4
Financhill
Back

Cognition Therapeutics 10K Form

Sell
12

CGTX
Cognition Therapeutics

Last Price:
$0.42
Seasonality Move:
1.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CGTX News And Ratings

See the #1 stock for the next 7 days that we like better than CGTX

CGTX Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-8.4M
Price / Cash Flow: 0
Annual Sales: $0.31
Price / Book: 1.37

Profitability

EPS (TTM): -0.87000
Net Income (TTM): $-34M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Cognition Therapeutics Earnings Forecast

Key Cognition Therapeutics Financial Ratios

  • Per Share Earnings over the last 6 years have been positive in 2 years.

Cognition Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CGTX
Website: cogrx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CGTX Technical Analysis vs Fundamental Analysis

Sell
12
Cognition Therapeutics (CGTX) is a Sell

Is Cognition Therapeutics a Buy or a Sell?